1533403-95-0
Chemical Structure
Lokivetmab
Synonym(s): Anti-Canine IL31 Recombinant Antibody; CAN34D3-65; PF-06443537
- CAS No.: 1533403-95-0
- Formula:N/A
- Molecular Weight:(147.51 kDa)
IUPAC Name: dimethyl heptanedioate-2,2,6,6-d4
SMILES: [Lokivetmab]
Biological Activity: Lokivetmab (Anti-Canine IL31 Recombinant Antibody) is an anti-canine IL-31 monoclonal antibody. Lokivetmab inhibits IL-31-mediated activation of pruritogenic signals in peripheral sensory neurons and reduces TH2-weighted inflammation. Lokivetmab demonstrates long-term efficacy in controlling pruritus and improving skin lesions in dogs with canine atopic dermatitis (CAD). Lokivetmab can be used for the research of atopic dermatitis (AD) in dogs[1].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Lokivetmab | 99.34% | Lokivetmab (Anti-Canine IL31 Recombinant Antibody) is an anti-canine IL-31 monoclonal antibody. Lokivetmab inhibits IL-31-mediated activation of pruritogenic signals in peripheral sensory neurons and reduces TH2-weighted inflammation. Lokivetmab demonstrates long-term efficacy in controlling pruritus and improving skin lesions in dogs with canine atopic dermatitis (CAD). Lokivetmab can be used for the research of atopic dermatitis (AD) in dogs. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
